文献速递慢性肾脏病遗传性与小管间质肾病肾血管病与高血压

轻度COL4A3-5相关疾病(Alport综合征)女性妊娠结局良好且遗传类型有助于个体化咨询

Reassuring pregnancy outcomes in women with mild COL4A3-5-related disease (Alport syndrome) and genetic type of disease can aid personalized counseling.
PubMed 文献 · Kidney Int · 2024-02-19

该多中心回顾性队列研究纳入192例COL4A3-5相关疾病(Alport综合征)妊娠,发现轻度Alport综合征女性妊娠结局良好,活产率100%,但妊娠期高血压和子痫前期发生率高于一般CKD G1-G2妊娠,ARAS妊娠结局较差,遗传类型可辅助个体化咨询。

要点

  • 轻度Alport综合征女性妊娠活产率100%,新生儿结局良好。
  • 妊娠期高血压发生率23%,子痫前期20%,高于一般CKD G1-G2妊娠。
  • ARAS妊娠早产风险较高,且是低出生体重和短孕周的独立预测因素。

核心结论

  • 轻度Alport综合征女性妊娠结局良好,但遗传类型应纳入个体化咨询。

研究设计与样本

  • 国际多中心回顾性队列研究(ALPART网络,17个中心),纳入192例妊娠(116名女性),包括XLAS 121例、ADAS 47例、ARAS 12例。

主要发现

  • 活产率100%,中位孕周39.0周,平均出生体重3135克。
  • 妊娠期高血压发生率23%,子痫前期发生率20%。
  • 妊娠后平均eGFR下降但仍处于正常范围(>90 ml/min/1.73m²),妊娠未显著影响eGFR斜率(孕前β=-1.030,孕后β=-1.349)。
  • ARAS妊娠结局较差,早产发生率3/11(27%),ARAS是低出生体重和短孕周的独立预测因素。

关键数值与推荐

  • 孕前中位eGFR>90 ml/min/1.73m²。
  • 妊娠期高血压参考一般CKD G1-G2妊娠发生率为4-20%。

临床怎么用

  • 对轻度Alport综合征女性可提供 reassuring 的孕前咨询,但需告知妊娠期高血压和子痫前期风险。
  • 咨询时应考虑遗传类型(尤其是ARAS),并结合经典危险因素(孕前肾功能、蛋白尿、慢性高血压)。

局限性

  • 回顾性设计,ARAS样本量小(12例妊娠),且部分蛋白尿数据缺失影响分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Individualized pre-pregnancy counseling and antenatal care for women with chronic kidney disease (CKD) require disease-specific data. Here, we investigated pregnancy outcomes and long-term kidney function in women with COL4A3-5 related disease (Alport Syndrome, (AS)) in a large multicenter cohort. The ALPART-network (mAternaL and fetal PregnAncy outcomes of women with AlpoRT syndrome), an international collaboration of 17 centers, retrospectively investigated COL4A3-5 related disease pregnancies after the 20th week. Outcomes were stratified per inheritance pattern (X-Linked AS (XLAS)), Autosomal Dominant AS (ADAS), or Autosomal Recessive AS (ARAS)). The influence of pregnancy on estimated glomerular filtration rate (eGFR)-slope was assessed in 192 pregnancies encompassing 116 women (121 with XLAS, 47 with ADAS, and 12 with ARAS). Median eGFR pre-pregnancy was over 90ml/min/1.73m2. Neonatal outcomes were favorable: 100% live births, median gestational age 39.0 weeks and mean birth weight 3135 grams. Gestational hypertension occurred during 23% of pregnancies (reference: 'general' CKD G1-G2 pregnancies incidence is 4-20%) and preeclampsia in 20%. The mean eGFR declined after pregnancy but remained within normal range (over 90ml/min/1.73m2). Pregnancy did not significantly affect eGFR-slope (pre-pregnancy β=-1.030, post-pregnancy β=-1.349). ARAS-pregnancies demonstrated less favorable outcomes (early preterm birth incidence 3/11 (27%)). ARAS was a significant independent predictor for lower birth weight and shorter duration of pregnancy, next to the classic predictors (pre-pregnancy kidney function, proteinuria, and chronic hypertension) though missing proteinuria values and the small ARAS-sample hindered analysis. This is the largest study to date on AS and pregnancy with reassuring results for mild AS, though inheritance patterns could be considered in counseling next to classic risk factors. Thus, our findings support personalized reproductive care and highlight the importance of investigating kidney disease-specific pregnancy outcomes.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Gosselink ME, Snoek R, Cerkauskaite-Kerpauskiene A, et al. Reassuring pregnancy outcomes in women with mild COL4A3-5-related disease (Alport syndrome) and genetic type of disease can aid personalized counseling. Kidney Int. 2024. PMID: 38382843. doi:10.1016/j.kint.2024.01.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。